The Ischemic Penumbra: Identification, Evolution and Treatment Concepts
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The concept of the ischemic penumbra is an important one for both basic investigators of cerebral ischemia and for clinicians who treat stroke patients. The ischemic penumbra has been defined in a variety of ways, but the most clinically relevant definition is that portion of the ischemic territory that is still potentially salvageable, if an appropriate treatment is given. Currently, three main challenges persist for those interested in the ischemic penumbra concept: how can this ischemic region be most accurately identified in stroke patients, what mechanisms of ischemic cell death are most important for progression from penumbra towards irreversible injury and what therapeutic modalities are most likely to impede the development of infarction? Much important information regarding each of these topics has become available recently and will be the focus of this paper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thresholds in cerebral ischemia - the ischemic penumbra.
Astrup, J., Siesjö, B. K., & Symon, L. (1981) · Stroke · doi:10.1161/01.str.12.6.723 · Cited by 2,820
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884 · cited 1×
“Non-protein-synthesis-requiring modalities of cell death likely predominate in ischemic regions with moderate to severe CBF declines, while protein-synthesis-dependent mechanisms may predominate in ischemic regions with less severe declines. These latter mechanisms of cell death may also predominate after reperfusion…”
BackgroundViability thresholds and the penumbra of focal ischemia
Hossmann, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360404 · Cited by 1,370 · cited 1×
“The concept of the ischemic penumbra is more than 20 years old and remains an important idea for both basic scientists and clinicians who are interested in stroke pathophysiology and treatment [”
BackgroundCalcium in Ischemic Cell Death
Kristián, T., & Siesjö, B. K. (1998) · Stroke · doi:10.1161/01.str.29.3.705 · Cited by 825 · cited 1×
“Over time an increasing number of potential components of the ischemic cascade have been identified [”
Heiss, W.-D., Graf, R., Löttgen, J., Ohta, K., Fujita, T., Wagner, R., Grond, M., & Weinhard, K. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199704000-00004 · Cited by 132
An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher, M., & Schaebitz, W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3196 · Cited by 112
Self-citation
Cited by
Donnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
Self-citationAnimal models of ischemic stroke and their application in clinical research
Kleinschnitz, C., Fluri, F., & Schuhmann, M. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s56071 · Cited by 650
Pathophysiology and therapy of experimental stroke
Hossmann, K.-A. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9008-1 · Cited by 475
“…because it is the conceptual basis not only for the progressive evolution of ischemic injury, but also for the therapeutic reversal of the acute neurological symptomatology arising from stroke (for reviews see Hossmann, 1994b; Heiss, 2000; Ginsberg, 2003; Fisher, 2004; Guadagno et al., 2004).”
BackgroundTreatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain
Cook, D. J., Teves, L., & Tymianski, M. (2012) · Nature · doi:10.1038/nature10841 · Cited by 443
Bench to Bedside: The Quest for Quality in Experimental Stroke Research
Dirnagl, U. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600298 · Cited by 349
Zhang, N., Komine-Kobayashi, M., Tanaka, R., Liu, M., Mizuno, Y., & Urabe, T. (2005) · Stroke · doi:10.1161/01.str.0000182241.07096.06 · Cited by 314
Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Di Gianfilippo, G., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 289
The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease
Chamorro, A., & Hallenbeck, J. (2006) · Stroke · doi:10.1161/01.str.0000200561.69611.f8 · Cited by 284
Kennedy, O. D., Herman, B. C., Laudier, D. M., Majeska, R. J., Sun, H. B., & Schaffler, M. B. (2012) · Bone · doi:10.1016/j.bone.2012.01.025 · Cited by 275
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
“Such tissue has varying degrees of residual blood flow and a reasonably prolonged time window for potential tissue salvage in some patients.(6) In both experimental stroke models and stroke patients, it has been reproducibly observed that residual cerebral blood levels vary in the ischemic zone, and that progression t…”
BackgroundSelf-citationImproving Outcome after Stroke: Overcoming the Translational Roadblock
Endres, M., Engelhardt, B., Koistinaho, J., Lindvall, O., Meairs, S., Mohr, J. P., Planas, A., Rothwell, N., Schwaninger, M., Schwab, M. E., et al. (2008) · Cerebrovascular Diseases · doi:10.1159/000118039 · Cited by 258
Plasma Adiponectin Levels and Five-Year Survival After First-Ever Ischemic Stroke
Efstathiou, S. P., Tsioulos, D. I., Tsiakou, A. G., Gratsias, Y. E., Pefanis, A. V., & Mountokalakis, T. D. (2005) · Stroke · doi:10.1161/01.str.0000177874.29849.f0 · Cited by 162
Kennedy, O. D., Laudier, D. M., Majeska, R. J., Sun, H. B., & Schaffler, M. B. (2014) · Bone · doi:10.1016/j.bone.2014.03.049 · Cited by 151
Hobohm, C., Günther, A., Grosche, J., Roßner, S., Schneider, D., & Brückner, G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20459 · Cited by 103
Cheung, W. Y., Fritton, J. C., Morgan, S. A., Seref-Ferlengez, Z., Basta-Pljakic, J., Thi, M. M., Suadicani, S. O., Spray, D. C., Majeska, R. J., & Schaffler, M. B. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2740 · Cited by 89
Metadata
- Authors
- Fisher, M.
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2003-12-29
- Volume
- 17
- Issue
- Suppl. 1
- Pages
- 1-6
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- OpenAlex
- W2008497452
- Cited by
- 151
- References
- 6
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.